Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers
Epigenetic modifiers acting through polypharmacology mechanisms are promising compounds with which to treat several infectious diseases. Histone deacetylase (HDAC) enzymes, mainly class I, and extra-terminal bromodomains (BET) are involved in viral replication and the host response. In the present s...
Main Authors: | Juliana Romano Lopes, Igor Muccilo Prokopczyk, Max Gerlack, Chung Man Chin, Jean Leandro Dos Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/12/1308 |
Similar Items
-
Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives
by: Mohammed Ghiboub, et al.
Published: (2021-04-01) -
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020-03-01) -
Histone Deacetylase 6 Inhibitor JS28 Prevents Pathological Gene Expression in Cardiac Myocytes
by: Vivien Ngo, et al.
Published: (2022-06-01) -
Epigenetic Therapy in Human Choriocarcinoma
by: Hisashi Narahara, et al.
Published: (2010-09-01)